Tom Fremd
Tom Fremd has made 39 investments in companies such as: Novalar Pharmaceuticals, StorageWay, Colorescience, Transcept Pharmaceuticals, Internet Generation Storage, NovoStent Corporation, NovaCardia, Avera Pharmaceutical, PartnerGate, Avantis Medical Systems, Verus Pharmaceuticals, SI-BONE, Pulmonx, Peninsula Pharmaceuticals, Pivot Medical, Somaxon Pharmaceuticals, Epirus Biopharmaceuticals, Cephren, Marketwired, GC Aesthetics, Cerexa Inc., Sequel Pharmaceuticals, Pure Life Renal, MAKO Surgical, moksha8 Pharmaceuticals, SkinMedica, Crown Laboratories, Kareo, Orexigen Therapeutics, Tobira Therapeutics, MINDBODY, KFx Medical, TigerConnect, ARYx Therapeutics, Bayhill Therapeutics, Glaukos, FinPay, Asthmatx, NeurogesX.
Location of Tom Fremd is San Francisco, United States.The free version of Angel Match provides limited data for Tom Fremd. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.
Tom Fremd is a CFO and he his investment types are: Micro VC.Tom Fremd focuses investing in industries such as: Finance, Financial Services, Health Care, Compliance, Enterprise, Messaging, mHealth, Privacy, Text Analytics, Medical Device, Consumer, Manufacturing, Pharmaceutical, Beauty, Cosmetics, E-Commerce, Fashion, Lifestyle, Women Founded, Health Diagnostics, Hospital, Cloud Computing, Electronic Health Record (EHR), Medical, Software.A short brief about investor: